Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Management of HCV-HIV and HBV-HIV coinfected patients].
Cacoub P, Piroth L. Cacoub P, et al. Among authors: piroth l. Gastroenterol Clin Biol. 2007 Oct;31(10):887-94. doi: 10.1016/s0399-8320(07)73986-6. Gastroenterol Clin Biol. 2007. PMID: 18166874 Free article. Review. French. No abstract available.
[Coinfection HIV-HBV and the liver].
Piroth L, Wendum D, Pialoux G. Piroth L, et al. Gastroenterol Clin Biol. 2001 Oct;25(10):875-7. Gastroenterol Clin Biol. 2001. PMID: 11852389 Free article. French. No abstract available.
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.
Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, Morand P, Goujard C, Pialoux G, Piroth L, Salmon-Céron D, Degott C, Cacoub P, Perronne C; ANRS HCO2 RIBAVIC Study Team. Carrat F, et al. Among authors: piroth l. JAMA. 2004 Dec 15;292(23):2839-48. doi: 10.1001/jama.292.23.2839. JAMA. 2004. PMID: 15598915 Clinical Trial.
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy.
Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C; ANRS Hc02-Ribavic Study Team. Bani-Sadr F, et al. Among authors: piroth l. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52. doi: 10.1097/01.qai.0000174649.51084.46. J Acquir Immune Defic Syndr. 2005. PMID: 16123681
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment.
Bani-Sadr F, Carrat F, Rosenthal E, Piroth L, Morand P, Lunel-Fabiani F, Bonarek M, Colin de Verdiere N, Pialoux G, Cacoub P, Pol S, Perronne C; ANRS HC02-Ribavic Study Team. Bani-Sadr F, et al. Among authors: piroth l. Clin Infect Dis. 2005 Dec 15;41(12):1806-9. doi: 10.1086/498312. Epub 2005 Nov 11. Clin Infect Dis. 2005. PMID: 16288408 Clinical Trial.
Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S; ANRS HC02 - Ribavic Study team. Bani-Sadr F, et al. Among authors: piroth l. AIDS. 2006 Feb 28;20(4):525-31. doi: 10.1097/01.aids.0000210606.63138.f5. AIDS. 2006. PMID: 16470116 Clinical Trial.
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study.
Sène D, Pol S, Piroth L, Goujard C, Dellamonica P, Moussali J, Rey D, Loustaud-Ratti V, Alric L, Chousterman M, Borsa-Lebas F, Boucher O, Séréni D, Cacoub P; GERMIVIC Study Group. Sène D, et al. Among authors: piroth l. Epidemiol Infect. 2007 Apr;135(3):409-16. doi: 10.1017/S0950268806006947. Epub 2006 Jul 25. Epidemiol Infect. 2007. PMID: 16863601 Free PMC article.
393 results